Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes

NCT01890122 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

647

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Alogliptin
DRUG: Metformin HCl
DRUG: Alogliptin and Metformin Fixed-Dose Combination (FDC)
DRUG: Alogliptin Placebo
DRUG: Metformin Placebo
DRUG: Alogliptin and Metformin FDC Placebo

Sponsor

Takeda